The numbers above come straight from the clinical trials that supported the FDA approval
Semaglutide has been studied for GLP-1 receptor signaling, incretin biology, central appetite regulation, beta-cell preservation, cardiovascular inflammation, NASH/NAFLD resolution, and neurodegenerative disease
Transcend , Planet Peptides , RPO , Revive , Nexaph , and Integrity all generate identical 70-75% satisfaction rates, identical generic praise patterns, identical complaint patterns, and identical neutral assessments concluding interchangeable positioning
Read on to learn the pros & cons of GLPs and how to get the most benefits if you chose to use GLP therapies
Identity: Confirmed via mass spectrometry and sequence verification to match GHRH (129) amide